EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining

Martyna Trzeszcz iD, Karolina Mazurec iD, Maciej Mazurec iD, Christopher Kobierzycki iD, Agnieszka Halon, Robert Jach iD

Cancers · 25.03.2026 · 18 (7) · 1056

DOI: 10.3390/cancers18071056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 25.03.2026. Verfasst von Martyna Trzeszcz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology and Clinical Cytology, University Hospital in Wroclaw, 50-556 Wroclaw, Poland. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The informative value of integrating high-risk human papillomavirus (HR-HPV) genotyping with cytology and p16/Ki67 dual-stain biomarker results, using limited and two types of extended genotyping assays, has not yet been evaluated.

Methods

A total of 32,724 screening test results between 2015 and 2024 were included. Limited HPV genotyping was performed using the Abbott RealTime High Risk HPV assay. Extended genotyping was performed using two assays: the Alinity m HR HPV and BD Onclarity HPV Assay. Trends in age-specific, cytology-specific, and p16/Ki67-specific HR-HPV prevalence and distribution were observed, and differences between limited and extended genotyping were examined.

Results

The overall HR-HPV positivity rate was 15.0%. HR-HPV prevalence was 13.9% in the limited genotyping group, 17.8% in in the Onclarity group 1, and 17.2% in the Alinity group 2, with a statistically significant difference in the proportions of positive/negative cases (p < 0.0001). No statistically significant difference was observed between extended genotyping groups (p = 0.706). In the Onclarity group: the highest p16/Ki67 positivity was observed for HPV 33/58 (100.0%) and HPV 31 (58.8%), while the lowest was for HPV 45 (18.2%), HPV 18 (25.0%) and HPV 59/56/66 (28.9%). In the Alinity group: the highest p16/Ki67 positivity was observed for HPV 16 (66.7%) and HPV 31/33/52/58 (58.8%).

Conclusions

Based on ten years of HPV-based cervical cancer screening data, this study demonstrates that genotype-specific HR-HPV information obtained through extended genotyping provides clinically relevant risk stratification when interpreted together with cytology and p16/Ki67 dual-stain results. These findings support an integrated screening approach combining molecular HPV testing, cytology, and immunocytochemical biomarkers to improve risk-based triage in cervical cancer screening.

Schlagwörter

Stichwörter der Autor:innen

HPV genotypingbiomarkerscervical cancer screeningcytologyextended genotypinghuman papillomavirus (HPV)limited genotypingp16/Ki67 dual staining

Autor:innen und Institutionen

  • Division of Pathology and Clinical Cytology, University Hospital in Wroclaw, 50-556 Wroclaw, Poland.
  • Corfamed Woman's Health Center, 50-322 Wroclaw, Poland.
  • Division of Clinical Pathology, Department of Clinical and Experimental Pathology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Division of Gynecologic Endocrinology, Jagiellonian University Medical College, 31-501 Krakow, Poland.

ORCID-Profile: Martyna Trzeszcz, Karolina Mazurec, Maciej Mazurec, Christopher Kobierzycki, Robert Jach

Zitieren

APA

Trzeszcz, M., Mazurec, K., Mazurec, M., Kobierzycki, C., Halon, A., & Jach, R. (2026). Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining. Cancers, 18(7), 1056. https://doi.org/10.3390/cancers18071056

Vancouver

Trzeszcz M, Mazurec K, Mazurec M, Kobierzycki C, Halon A, Jach R. Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining. Cancers. 2026;18(7):1056. doi:10.3390/cancers18071056

BibTeX
@article{Trzeszcz2026,
  author = {Trzeszcz, Martyna and Mazurec, Karolina and Mazurec, Maciej and Kobierzycki, Christopher and Halon, Agnieszka and Jach, Robert},
  title = {Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1056},
  doi = {10.3390/cancers18071056}
}
Kostenlos starten →